Clinical Trials Directory

Trials / Completed

CompletedNCT00266123

Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients

A Randomized Open-Label Study to Compare the Safety and Efficacy of Two Different Sirolimus Regimens With a Tacrolimus + Mycophenolate Mofetil Regimen in De Novo Renal Allograft Recipients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
420 (planned)
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To demonstrate the superiority of SRL + TAC elimination + corticosteroids (Group I) and SRL + MMF + corticosteroids (Group II) to TAC + MMF + corticosteroids (Group III) with respect to renal allograft function at month 12 post-transplantation.

Conditions

Interventions

TypeNameDescription
DRUGSirolimus

Timeline

Start date
2004-03-01
Completion
2007-07-01
First posted
2005-12-15
Last updated
2007-12-27

Source: ClinicalTrials.gov record NCT00266123. Inclusion in this directory is not an endorsement.